Fibrinogen Human Completed Phase 2 Trials for Aortic Aneurysms Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00701142HaemocomplettanĀ® P During Aortic Replacement